Antiviral Drug Discovery and Development: Current Innovations and Future Trends

A special issue of Future Pharmacology (ISSN 2673-9879).

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 783

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China
Interests: antiviral drug; medicinal chemistry; drug design; new drug modalities
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Infections caused by viruses have been a prominent factor contributing to human mortality since ancient times. Despite the escalating number of antiviral medications approved for clinical use, prolonged usage can readily result in the emergence of drug resistance and adverse effects. The discovery of safe and efficacious antiviral medications is therefore pivotal in the management of viral infections. 

Viral infections pose a significant threat to human health. For medicinal chemists, the research and development of antiviral drugs should not only focus on current chronic viral infections such as AIDS and hepatitis B, which are challenging to cure, but should also adopt a strategic vision by targeting potential future virus outbreaks and developing broad-spectrum antiviral drugs. This critical situation necessitates the proficient utilization of classical medicinal strategies for antiviral drug development, and the simultaneously fostering of innovative research paradigms in order to greatly enhance the success rate of such endeavors. This Special Issue warmly welcomes novel research in the field of antiviral drugs.

In this Special Issue, original research articles and reviews are welcome. 

Prof. Dr. Peng Zhan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antiviral drug discovery
  • rational drug design
  • phenotypic screening
  • structure optimization
  • structure–activity relationship
  • structural biology
  • molecular simulation
  • virtual screening
  • chemical synthesis
  • combinatorial chemistry
  • computational chemistry
  • molecular hybridization
  • scaffold hopping
  • bioisosterism
  • prodrug
  • mechanic-based drug design
  • transition state theory
  • targeted covalent inhibitors
  • substrate envelope
  • high-throughput synthesis
  • high-throughput protein crystallography
  • parallel medicinal chemistry
  • spatial-patterned interaction
  • multivalent interaction
  • molecular tongs
  • molecular tweezers
  • geometry-matching topography
  • membrane-disrupting molecules
  • supramolecular drug
  • proximity-induced nucleic acid degrader
  • proteolysis targeting chimera
  • proximity-mediated effects
  • sequence-based design
  • sub-stoichiometric modulation
  • artificial intelligence
  • drug resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop